GSK-1322322
CAS No. 1152107-25-9
GSK-1322322( Lanopepden | GSK-322 )
Catalog No. M10536 CAS No. 1152107-25-9
A novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 901 | In Stock |
|
| 10MG | 1207 | In Stock |
|
| 25MG | 1796 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK-1322322
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens.
-
DescriptionA novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens, including MDR Streptococcus pneumoniae and MRSA; inhibits S. pneumoniae ATCC 49619 with MIC of 0.12-0.5 ug/mL.
-
In Vitro——
-
In Vivo——
-
SynonymsLanopepden | GSK-322
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number1152107-25-9
-
Formula Weight479.56
-
Molecular FormulaC22H34FN7O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 30 mg/mL (62.56 mM)
-
SMILESCC1=NC(=C(C(=N1)N2CCN3CCOCC3C2)F)NNC(=O)C(CC4CCCC4)CN(C=O)O
-
Chemical NameN-((R)-2-(cyclopentylmethyl)-3-(2-(5-fluoro-6-((S)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)-2-methylpyrimidin-4-yl)hydrazinyl)-3-oxopropyl)-N-hydroxyformamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Ginsenoside Rg4
Ginsenoside Rg4 is isolated from the leaves of Panax ginseng C. A. Meyer. Ginsenoside Rg4 is a protopanaxatriol type ginsenoside with anti-septic, anti-diabetic, wound healing, immune-stimulatory, and anti-antioxidant properties.
-
Ceftobiprole medocar...
Ceftobiprole medocaril is the parenteral prodrug of Ceftobiprole. Ceftobiprole is a broad-spectrum cephalosporin with activity against Methicillin-resistant staphylococcus aureus (MRSA).
-
N-Acetyltyramine
N-Acetyltyramine is the active compound extracted from a fermentation broth of strain M3-10 which produces quorum-sensing inhibitor (QSI) compound. N-Acetyltyramine inhibits Chromobacterium violaceum ATCC 12472 violacein production and virulence factors, such as pyoverdine production, as well as swarming and twitching motilities, produced by Pseudomonas aeruginosa PAO1.
Cart
sales@molnova.com